1. Home
  2. INM vs PLYM Comparison

INM vs PLYM Comparison

Compare INM & PLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INM
  • PLYM
  • Stock Information
  • Founded
  • INM 1981
  • PLYM 2011
  • Country
  • INM Canada
  • PLYM United States
  • Employees
  • INM N/A
  • PLYM N/A
  • Industry
  • INM Biotechnology: Pharmaceutical Preparations
  • PLYM Real Estate Investment Trusts
  • Sector
  • INM Health Care
  • PLYM Real Estate
  • Exchange
  • INM Nasdaq
  • PLYM Nasdaq
  • Market Cap
  • INM 3.2M
  • PLYM 724.7M
  • IPO Year
  • INM N/A
  • PLYM 2017
  • Fundamental
  • Price
  • INM $2.78
  • PLYM $15.85
  • Analyst Decision
  • INM
  • PLYM Buy
  • Analyst Count
  • INM 0
  • PLYM 9
  • Target Price
  • INM N/A
  • PLYM $21.44
  • AVG Volume (30 Days)
  • INM 5.8M
  • PLYM 442.6K
  • Earning Date
  • INM 05-12-2025
  • PLYM 08-06-2025
  • Dividend Yield
  • INM N/A
  • PLYM 6.02%
  • EPS Growth
  • INM N/A
  • PLYM 600.05
  • EPS
  • INM N/A
  • PLYM 3.05
  • Revenue
  • INM $4,920,990.00
  • PLYM $180,505,000.00
  • Revenue This Year
  • INM N/A
  • PLYM $2.17
  • Revenue Next Year
  • INM N/A
  • PLYM $10.13
  • P/E Ratio
  • INM N/A
  • PLYM $5.23
  • Revenue Growth
  • INM N/A
  • PLYM N/A
  • 52 Week Low
  • INM $1.72
  • PLYM $12.70
  • 52 Week High
  • INM $15.70
  • PLYM $24.71
  • Technical
  • Relative Strength Index (RSI)
  • INM 47.36
  • PLYM 43.17
  • Support Level
  • INM $2.69
  • PLYM $15.85
  • Resistance Level
  • INM $3.28
  • PLYM $16.27
  • Average True Range (ATR)
  • INM 0.26
  • PLYM 0.38
  • MACD
  • INM -0.03
  • PLYM -0.05
  • Stochastic Oscillator
  • INM 8.79
  • PLYM 17.13

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

About PLYM Plymouth Industrial REIT Inc.

Plymouth Industrial REIT Inc is a full-service, vertically integrated, self-administered, and self-managed Maryland corporation. It is focused on the acquisition, ownership, and management of single and multi-tenant Class B industrial properties, including distribution centers, warehouses, and light industrial properties, located in secondary and primary markets across the United States. The company has one reportable segment, which is Industrial properties. The majority of its property portfolio is spread across Florida, Ohio, Indiana, Tennessee, Illinois and Georgia, among others. It receives income from the rental revenue through its properties.

Share on Social Networks: